Amgen, one of the world’s leading biotech companies, has announced the establishment of its first center in India, located in Hyderabad. After an extensive evaluation of multiple cities across the country, Amgen’s decision to set up in Hyderabad is a significant endorsement of Telangana’s growing reputation as a mature and thriving life sciences ecosystem.

Expressing pride in this achievement, Shakthi M Nagappan CEO of Telangana Lifesciences, stated on Linkedin, "I am particularly proud of our team's relentless efforts over the past several months to make this a reality. The proactive approach, seamless support, and unwavering commitment shown by our government were instrumental in this decision."
."

Amgen’s Hyderabad center will house 3,000 professionals and play a crucial role in the company’s global mission to deliver life-changing therapies. Operations are set to begin later this year, marking a new era of innovation and collaboration in Telangana’s life sciences sector.